Agoracom Blog Home

Author Archive

CLIENT FEATURE: American Creek $AMK.ca encounters high grade #Gold / #Silver at Treaty Creek, same system as Seabridge Gold $SA $SEA.ca $SKE.ca $TUD.ca $PVG $MRO.ca

Posted by AGORACOM at 11:46 AM on Sunday, February 17th, 2019

AMK: TSX-V, OTCBB: ACKRF

  • Intersected various mineralized zones
  • Most significant was 337.5m of continuous mineralization grading 0.76 g/t gold from 2 to 339.5m depth,
  • Including a higher grade intercept of 124.5m grading 0.98 g/t gold from 53.0 to 177.5m

OTHER RECENT HIGHLIGHTS

  • Reported on First Two 2018 Holes at Treaty Creek Including 1.036 G/T Gold over 121.8 Meters and First Sighting of Visible Gold in Core Read More
  • Encountered numerous high grade gold/silver intercepts in preliminary drilling at the new HC zone at the Treaty Creek Project Read More
  • Additional gold discovery of 5.1m of 9.57 g/t gold from 249.35m to 254.45m Read More

View Presentation

FULL DISCLOSURE: American Creek Resources is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: FanLogic ($FLGC) The Monetization Platform For Athletes, Actors and Social Media Celebrities

Posted by AGORACOM at 11:20 AM on Friday, February 15th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564645/hub/Fanlogic_Logo.jpg
  • Expanded Database of Users To Over 1 Million in November
  • Helps Athletes, Actors and Celebrities Convert Followers Into Paying Fans
  • FanLogic Platform Provides Fans With VIP Access, Contests and Prizes That Generate Long-Term, Recurring Revenues For The Celebrity
  • FanLogic Provides Celebrities With Smart and Fun Tools To Directly Engage Their Fans
  • With the Exception Of The Top 1% Of Celebrities, Most Other Celebrities Are Unable To Monetize Their Audiences Beyond Simple Advertising and Sponsored Post

Alberto “El Patron” Del Rio READ MORE

NASCAR Xfinity Series Race Team READ MORE

FULL DISCLOSURE: FanLogic Interactive is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: $GRAT Gratomic Making 1st Step toward Commercialization with Launch of Graphene Ultra Efficient Tires $DNI.ca $LLG.ca

Posted by AGORACOM at 9:58 AM on Wednesday, February 13th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564608/hub/Gratomic_large_new.jpg
  • Launching Graphene Ultra Fuel Efficient Tires (GUET) toward the end of summer 2019
  • Gratomic certification and terrain testing targeted for completion in Q3, 2019
  • Gratomic anticipates GUET to be the first range of Graphene-enabled ultra fuel-efficient tires
  • Gratomic will now target mass market sales demand via Graphene Ultra Fuel Efficient Tires (GUET)

About Gratomic Inc.

Gratomic is an advanced material company focused on mine to market commercialization of graphite products, most notably high-value graphene-based components for a range of mass market products.

FULL DISCLOSURE: Gratomic is an advertising client of AGORA Internet Relations Corp.

IntellaEquity $IEQ sells 51% of Marcon International (USA) Inc for CDN$981,499

Posted by AGORACOM at 7:12 AM on Tuesday, February 12th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564614/hub/IntellaEquity_Inc._LOGO_v1.jpg
  • Sold 51% of all of the issued and outstanding securities of Marcon International to GRX Industries Inc.
  • GRX acquired the Securities for an aggregate purchase price of CDN$ 981,499.71, which was satisfied through the assumption of debt and debt forgiveness.
  • This transaction removes a significant amount of debt off of the Corporation’s balance sheet and will free up cash flow for investing activities

Toronto, Ontario–(February 12, 2019) – IntellaEquity Inc. (CSE: IEQ) (the “Corporation” or “IntellaEquity”) announces that it has sold 51% of all of the issued and outstanding securities (the “Securities”) in the capital of Marcon International (USA) Inc. (“Marcon”) to GRX Industries Inc. (“GRX), an arm’s length third party. Pursuant to the share purchase agreement, GRX acquired the Securities for an aggregate purchase price of CDN$ 981,499.71, which was satisfied through the assumption of debt and debt forgiveness.

“The sale of the Securities will allow the Corporation to focus on its mandate as a merchant bank and not an operator,” said Allen Lone, President of the Corporation. “This transaction removes a significant amount of debt off of the Corporation’s balance sheet and will free up cash flow for investing activities. As GRX is directly owned by a US resident, Marcon will now be able to qualify for 100% set-aside small business contracts with the US government. This will allow Marcon to continue to grow its business. Through its 49% ownership interest, the Corporation will benefit from the expanding business of Marcon.”

About the Corporation

IntellaEquity is a publicly traded company, it is a diversified investment and venture capital firm focused on providing investors with long-term capital growth by investing in a portfolio of undervalued companies and assets. The investment portfolio may be comprised of securities of both public and private issuers primarily in technology, artificial intelligence, blockchain and may also include investments in certain other sectors, including water, green energy, and alternative energy. Target investments shall encompass companies at all stages of development, including pre-initial public offering and/or early-stage companies requiring start-up or development capital, as well as intermediate and senior companies.

Corporation contact:

Allen Lone
President and CEO

905-338-2323
Email: [email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Cautionary Note regarding Forward-looking Statements

This news release includes certain information and forward-looking statements about management’s view of future events, expectations, plans and prospects that constitute forward-looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Although the Corporation believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statement will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

CLIENT FEATURE: Applied Biosciences $APPB Rewards Shareholders with Dividend from JUUL Labs $JUUL $WMD.ca

Posted by AGORACOM at 10:17 AM on Monday, February 11th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png

OTCQB: APPB

  • Received a capital distribution of $186,000 from its investment in JUUL Labs, Inc. (JUUL).
  • Altria Group Inc. (NYSE: MO) invested $12.8bn (35%), valuing JUUL at $38 billion.
  • JUUL is one of the fastest growing companies in the US, growing revenue to over $1 billion in a few short years.
  • The global e-cig and vaporizer market is one of the fastest growing consumer markets, expected to reach $49 billion by the end of 2024
  • APPB recently acquired a majority stake in Trace Analytics, Inc., a leading testing and analytics company.
  • APPB also has a early stage investment in Hightimes Magazine
  • APPB: Market Cap of 20$M US with 10m shares outstanding

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp

CLIENT FEATURE: FanLogic ($FLGC) The Monetization Platform For Athletes, Actors and Social Media Celebrities

Posted by AGORACOM at 10:50 AM on Friday, February 8th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564645/hub/Fanlogic_Logo.jpg
  • Expanded Database of Users To Over 1 Million in November
  • Helps Athletes, Actors and Celebrities Convert Followers Into Paying Fans
  • FanLogic Platform Provides Fans With VIP Access, Contests and Prizes That Generate Long-Term, Recurring Revenues For The Celebrity
  • FanLogic Provides Celebrities With Smart and Fun Tools To Directly Engage Their Fans
  • With The Exception Of The Top 1% Of Celebrities, Most Other Celebrities Are Unable To Monetize Their Audiences Beyond Simple Advertising and Sponsored Post

Alberto “El Patron” Del Rio READ MORE

NASCAR Xfinity Series Race Team READ MORE

FULL DISCLOSURE: FanLogic Interactive is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: GGX Gold’s 2018 Exploration Program at Gold Drop Demonstrates High Grade Potential $K.ca $GZD.ca $TUSK.ca $XIM.ca

Posted by AGORACOM at 9:18 AM on Thursday, February 7th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564602/hub/ggx_large.png

The 2018 Exploration program Returned Results Including:

  • The most significant gold drill intersections (core length) from the phase 3 diamond drilling on the COD vein are as follows:
    • COD18-3: 14.62 g/t Au over 2.1 metres;
    • COD18-26: 10.30 g/t Au over 1.4 metres recovered core (within 2.35-metre interval);
    • COD18-28: 11.30 g/t Au over 0.51 metre;
    • COD18-33: 8.65 g/t Au over 2.98 metres;
    • COD18-34: 6.16 g/t Au over 3.41 metres;
    • COD18-37: 8.23 g/t Au over 3.95 metres;
    • COD18-45: 50.10 g/t Au over 2.05 metres;
    • COD18-46: 54.90 g/t Au over 1.47 metres;
    • COD18-49: 9.52 g/t Au over 1.47 metres;
    • COD18-54: 7.60 g/t Au over 1.66 metres.

The 2018 drilling program also tested the continuation of the Everest vein, which is located southwest of the COD vein work site. Chip samples collected in 2017 across the approximate 0.4-metre-wide vein exposure returned up to 52.8 g/t gold and 377 g/t silver, while a grab sample of a quartz vein boulder broken off the outcrop by the excavator returned 81.8 g/t gold and 630 g/t silver (news release of Aug. 21, 2017).

The Everest vein 2018 drill holes are located approximately 350 to 800 metres south of the area of 2017 and 2018 COD vein drill holes. High gold intersections (core length) from the phase 3 drill program at the Everest vein include (news release of July 19, 2018, and Sept. 13, 2018):

EVE18-5: 10.55 g/t Au over 0.45 metre;

EVE18-12: 12.45 g/t Au over 0.85 metre.

GGX HUB HOME  / CORPORATE PROFILE

FULL DISCLOSURE: GGX Gold is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: Applied Biosciences $APPB Investment in JUUL Labs Paying Dividends for Shareholders $HTIM $JUUL $WMD

Posted by AGORACOM at 10:19 AM on Wednesday, February 6th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Received a capital distribution of approximately $186,000 from its investment in JUUL Labs, Inc. (JUUL)
  • The investment remains on the balance sheet under Equity Investments, the company has begun a strategic review of options for the remaining equity stake. 
  • Altria Group Inc. (NYSE: MO) on December 20, 2018 announced it had invested $12.8bn in vaping company Juul Labs, a 35% stake valuing JUUL at $38 billion.
  • APPB also recently acquired a majority stake in Trace Analytics, Inc., a leading testing and analytics company with proven revenues
  • Applied BioSciences early stage investment in Hightimes Magazine is valued at approximately $1.75 Million at assumed IPO Pricing of $11.00
  • APPB has a market cap of $15m US & 10m S/O

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp.

Applied Biosciences $APPB Receives Distribution from Investment in JUUL Labs $HTIM $WMD $JUUL

Posted by AGORACOM at 11:28 AM on Tuesday, February 5th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Received a capital distribution of approximately $186,000 from its investment in JUUL Labs
  • Altria Group Inc. (NYSE: MO) invested $12.8bn in vaping company Juul Labs, a (35% stake) valuing JUUL at $38 billion
  • The global e-cig and vaporizer market is one of the fastest growing consumer markets and has been recently valued at $9.0 billion and expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024
  • APPB has a market cap of $15m US & 10m S/O

LOS ANGELES, Feb. 05, 2019 (GLOBE NEWSWIRE) — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, announced that has received a capital distribution of approximately $186,000 from its investment in JUUL Labs, Inc. (JUUL).   The company has made strategic investments in select companies they believed to be innovators in the consumer space.  The investment remains on the balance sheet under Equity Investments, but the company has begun a strategic review of options for the remaining equity stake. 

Altria Group Inc. (NYSE: MO) on December 20, 2018 announced it had invested $12.8bn in vaping company Juul Labs, a 35% stake valuing JUUL at $38 billion.  Howard Willard, Altria’s CEO said in a statement that the move was an effort to “prepare for a future where adult smokers overwhelmingly choose non-combustible products over cigarettes.” 

JUUL has become a success story and one of the fastest growing companies in the US, growing revenue to over $1 billion in a few short years.  Their brand has become synonymous with vaping and the e-cigarette market. 

The global e-cig and vaporizer market is one of the fastest growing consumer markets and has been recently valued at $9.0 billion and expected to grow at a CAGR of 23.6% and reach $49 billion by the end of 2024, according to Research Nestor (www.researchnester.com).

The company continues to make select investments in companies that can help shape the product roadmap and development of new products and potential partnerships.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website:www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Vertical Exploration $VERT.ca Announces Wollastonite Research and Development Results

Posted by AGORACOM at 9:00 AM on Tuesday, February 5th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564648/hub/vertical.png
  • Successful completion of Phase Three trials involving cannabis grown with wollastonite (CaSiO3) as a soil additive
  • Phase Three trials BCBD measured and recorded significant improvements in root mass, powdery mildew control and pest elimination.
  • Optimal results occurred with an admixture rate of 10% to 15% Wollastonite to the growth medium

VANCOUVER, BC / February 5, 2019 / VERTICAL EXPLORATION INC. (TSX-V: VERT) (“Vertical” or the Company”) is pleased to announce the successful completion of Phase Three trials involving cannabis grown with wollastonite (CaSiO3) as a soil additive at BC Bud Depot’s (BCBD) ACMPR-licenced Research and Development facilities in Vancouver, BC. The positive Phase Three trials build on the success of Phase Two Trials, which included samples of marijuana grown with 15% wollastonite from the Company’s St. Onge project being entered in an international growers’ competition, winning first place overall for Best Flower at the August 2018 Kootenay Cannabis Cup in Cranbrook, BC. (see October 2, 2018 news release.)

In the Phase Three trials BCBD measured and recorded significant improvements in root mass, powdery mildew control and pest elimination. In every case the most optimal results occurred with an admixture rate of 10% to 15% wollastonite to the growth medium. Most notably, powdery mildew, the most common fungal blight to affect Cannabis sativa, was virtually undetectable with wollastonite admixture above 10%. An admixture above 10% wollastonite also correlated with sharp reductions in the presence of thrips and fungus gnats, insect pests with a sub-soil life phase in which the wollastonite crystals lacerate and impale their soft bodies. At a microscopic level, wollastonite’s needle-like structure penetrates soft-bodied insect larvae and pupae, interrupting the life cycle without the use of pesticides. Wollastonite’s unique properties also allow it to break down into calcium, magnesium and silicon in a highly bio-available form that balances soil PH throughout the growth cycle – this allows the cannabis plants to uptake silicic acid and promotes strong cell walls that better resist insect feeding and spore penetration, supporting increased growth and elevated product yields.

“We recorded a dramatic elevation of overall health among plants grown with wollastonite,” stated Matthew Harvey, CEO of BCBD. “The wollastonite group produced consistently low levels of powdery mildew — little to none – appearing later in the growth cycle. Roots, meanwhile, showed extreme vigour, growing dense and white with no sign of yellowing. Root health indicates a plant’s ability to resist disease and to support high yields of high-quality of finished marijuana.

According to Mr. Harvey the findings of the Phase Three BCBD wollastonite study indicate a major financial implication for the cannabis industry, where a trend towards cultivation of expansive plant canopies creates a powerful incentive for effective and efficient methods of crop protection and production.

As Mr. Harvey explained, “Large-scale cultivators need every tool at their disposal to improve plant health and avoid crop losses – a 10% to 20% loss in crop production due to a preventable outbreak of a destructive fungal pathogen can equate to millions of dollars of lost product. Companies that take crop protection seriously are looking for cost-effective soil additives that not only nourish plants but build resilience against the pests and pathogens that threaten profits. Our findings show wollastonite to be a critical tool for both cannabis crop protection and top-end production in a market where quality is of vital importance. It is no longer acceptable to spray fungicides on marijuana: natural prevention is the key and wollastonite is the answer.

Vertical’s CEO Peter Swistak commented: “We are very excited by these excellent Phase Three results which prove that wollastonite is a very appealing natural growing additive for the cannabis industry because it couples crop protection with product improvement, resulting in a more natural and healthier product for consumers.”

With the highly successful completion of these Phase Three cannabis trials at BCBD, Vertical is now moving aggressively forward with its plans to test market its high-quality St. Onge wollastonite to both micro-producers and large-scale cannabis companies. Vertical believes that the cannabis industry offers significant revenue potential for the company and anticipates providing further updates on its cannabis testing and marketing efforts in the near future.

ABOUT VERTICAL EXPLORATION

Vertical Exploration’s mission is to identify, acquire, and advance high potential mining prospects located in North America for the benefit of its stakeholders. The Company’s flagship St-Onge Wollastonite property is located in the Lac-Saint-Jean area in the Province of Quebec.

ON BEHALF OF THE BOARD
Peter P. Swistak, President

FOR FURTHER INFORMATION PLEASE CONTACT:

Telephone: 1-604-683-3995
Toll Free: 1-888-945-4770

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING STATEMENTS: This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR in Canada (available at www.sedar.com).

SOURCE: Vertical Exploration Inc.